Globus Medical, Inc.
GMED · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,519,355 | $1,568,476 | $1,022,843 | $958,102 |
| % Growth | 60.6% | 53.3% | 6.8% | – |
| Cost of Goods Sold | $1,035,479 | $548,174 | $263,725 | $239,223 |
| Gross Profit | $1,483,876 | $1,020,302 | $759,118 | $718,879 |
| % Margin | 58.9% | 65.1% | 74.2% | 75% |
| R&D Expenses | $163,754 | $124,010 | $73,015 | $97,346 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $981,048 | $643,410 | $432,117 | $408,149 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $173,083 | $119,740 | $26,035 | $41,431 |
| Operating Expenses | $1,317,885 | $887,160 | $531,167 | $546,926 |
| Operating Income | $165,991 | $133,142 | $227,951 | $171,953 |
| % Margin | 6.6% | 8.5% | 22.3% | 17.9% |
| Other Income/Exp. Net | -$45,269 | $32,251 | $15,068 | $8,454 |
| Pre-Tax Income | $120,722 | $165,393 | $243,019 | $180,407 |
| Tax Expense | $17,738 | $42,520 | $52,850 | $31,216 |
| Net Income | $102,984 | $122,873 | $190,169 | $149,191 |
| % Margin | 4.1% | 7.8% | 18.6% | 15.6% |
| EPS | 0.76 | 1.09 | 1.89 | 1.48 |
| % Growth | -30.3% | -42.3% | 27.7% | – |
| EPS Diluted | 0.75 | 1.07 | 1.85 | 1.44 |
| Weighted Avg Shares Out | 135,726 | 113,087 | 100,469 | 100,734 |
| Weighted Avg Shares Out Dil | 137,863 | 114,630 | 102,643 | 103,623 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $20,130 | $14,233 | $9,297 |
| Interest Expense | $4,189 | $0 | $0 | $0 |
| Depreciation & Amortization | $254,024 | $144,733 | $68,252 | $69,867 |
| EBITDA | $473,725 | $346,583 | $304,503 | $264,725 |
| % Margin | 18.8% | 22.1% | 29.8% | 27.6% |